Combination immunotherapy shrinks melanoma brain metastases: Ipilimumab, nivolumab provide durable responses in stage 4 patients with worst prognosis

www.sciencedaily.com

Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial.

  • 0 Likes

  • 0 Comments